adenosine 5'-tetraphosphate has been researched along with bq 123 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guranowski, A; Huang, T; Hub, F; Jankowski, J; Jankowski, V; Jemielity, J; Kowalska, J; Loddenkemper, C; Schuchardt, M; Tölle, M; van der Giet, M; Wiedon, A; Zidek, W | 1 |
| Burnstock, G | 1 |
2 other study(ies) available for adenosine 5'-tetraphosphate and bq 123
| Article | Year |
|---|---|
Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor.
Topics: Adenine Nucleotides; Animals; Antihypertensive Agents; Blood Pressure; Cells, Cultured; Endothelial Cells; Humans; Kidney; Peptides, Cyclic; Purinergic P2 Receptor Agonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X; Vasoconstriction; Vasoconstrictor Agents | 2008 |
Endothelium-derived vasoconstriction by purines and pyrimidines.
Topics: Adenine Nucleotides; Animals; Antihypertensive Agents; Blood Pressure; Cells, Cultured; Endothelial Cells; Humans; Kidney; Peptides, Cyclic; Purinergic P2 Receptor Agonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X; Vasoconstriction; Vasoconstrictor Agents | 2008 |